Gaudium IVF IPO
ListedMainboardOpens 20 February 2026Closes 24 February 2026
Gaudium IVF & Women Health Ltd. is a leading fertility care provider in India specializing in In Vitro Fertilization (IVF) and assisted reproductive technologies (ART). Operating through a hub-and-spoke model with 7…
Gaudium IVF & Women Health Ltd. is a leading fertility care provider in India specializing in In Vitro Fertilization (IVF) and assisted reproductive technologies (ART). Operating through a hub-and-spoke model with 7 hubs and 28 spokes, the company provides high-end fertility treatments and gynecological care. It is the first dedicated fertility services company to enter the Indian public markets, leveraging high-tech labs and medical tourism inflows.
Show moreShow less
Key ratios
As per RHP / filingsTimeline
IPO Opens
20 Feb 2026
IPO Closes
24 Feb 2026
Allotment
25 Feb 2026
Listing
27 Feb 2026
IPO Timeline & Listing Details
| Event | Date |
|---|---|
| IPO Open Date | 20 February 2026 |
| IPO Close Date | 24 February 2026 |
| Allotment Date | 25 February 2026 |
| Listing Date | 27 February 2026 |
Investment Categories
| Category | Lots | Amount |
|---|---|---|
Retail (Min) | 1 | ₹14,931 |
Retail (Max)Just less than ₹2,00,000 | 13 | ₹1,94,103 |
SHNI (Min)Just above ₹2,00,000 | 14 | ₹2,09,034 |
SHNI (Max)Below ₹10,00,000 | 66 | ₹9,85,446 |
BHNIAbove ₹10,00,000 | 67 | ₹10,00,377 |
IPO Reservation Details
| Category | Reservation |
|---|---|
| QIB (Qualified Institutional Buyer) | 50.00% |
| NII (Non-Institutional Investor) | 15.00% |
| SHNI (Small Non-Institutional Investor) | 5.00% |
| BHNI (Big Non-Institutional Investor) | 10.00% |
| Retail | 35.00% |
| Total | 100.00% |
IPO Objectives
- Funding capital expenditure for establishment of 19 New IVF Centers (₹50.00 Cr).
- Repayment or prepayment of certain outstanding loans (₹20.00 Cr).
- General Corporate Purposes.
Strengths
- The company benefits from a First-mover advantage as the first pure-play fertility services firm to be listed in the Indian market.
- It demonstrates Exceptional Profitability, maintaining an EBITDA margin of approximately 40% and a robust RoNW of over 40%.
- The business operates a Scalable Asset-Light Model through its hub-and-spoke infrastructure, allowing for efficient expansion.
- It holds Strong Brand Value under the leadership of Dr. Manika Khanna, backed by over 10 years of clinical expertise and patient trust.
Weaknesses
- The company faces a High Staff Attrition Risk, with reported turnover reaching 63% for FY25 among skilled doctors and embryologists.
- There is significant Revenue Concentration, with over 75% of total income currently derived from the Delhi-NCR hub.
- The business is subject to Regulatory Sensitivity, as any shifts in the Assisted Reproductive Technology (ART) Act or surrogacy laws could directly impact operations.
Financial Performance
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets (₹ Cr.) | 106.62 | 88.51 | 51.01 |
| Revenue (₹ Cr.) | 49.75 | 70.96 | 48.15 |
| PAT (₹ Cr.) | 12.51 | 19.13 | 10.32 |
| Net Worth (₹ Cr.) | 58.85 | 46.3 | 26.99 |
Peer Comparison
| Company | P/B Ratio | P/E Ratio | RONW (%) | Net Worth (₹ Cr.) |
|---|---|---|---|---|
| Gaudium IVF and Women | 10.48 | 22.99 | 41.71% | 58.85 |
Subscription Details
Daily Bids Status
| Category | Day 1 | Day 2 | Day 3 |
|---|---|---|---|
| QIB | 0x | 0.02x | 1.62x |
| NII | 0.91x | 4.64x | 14.05x |
| S-HNI | 1.65x | 6.87x | 16.73x |
| B-HNI | 0.54x | 3.52x | 12.71x |
| RII | 1.42x | 4.06x | 7.6x |
| Total | 0.9x | 3.03x | 7.27x |
Overall Subscription Statistics
| Category | Shares Offered | Shares Bid | Bid Amount (₹ Cr) |
|---|---|---|---|
| QIB | 41,77,240 | 67,85,478 | 53.61 |
| NII | 31,32,930 | 4,40,22,069 | 347.77 |
| Small NII | 10,44,310 | 1,74,66,435 | 137.98 |
| Big NII | 20,88,620 | 2,65,55,634 | 209.79 |
| RII | 73,10,170 | 5,55,42,942 | 438.79 |
| Total | 1,46,20,340 | 10,63,50,489 | 840.17 |
Company Details
- Gaudium IVF & Women Health Ltd.
- B1/51, Janak Puri, New Delhi, 110058
- 011-4885 8585
- compliance@gaudiumivfcentre.com
- https://www.gaudiumivf.com/
Registrar Details
- Bigshare Services Pvt.Ltd.
- +91-22-6263 8200
- ipo@bigshareonline.com
- https://ipo.bigshareonline.com/
Frequently Asked Questions
What is the Gaudium IVF IPO price band?
How much should I invest in Gaudium IVF IPO?
What is the listing date of Gaudium IVF IPO?
Gaudium IVF IPO News & Updates
Follow the latest updates for Gaudium IVF IPO, including grey market moves and allotment news.
Gaudium IVF IPO IPO Pages
Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.
Gaudium IVF IPO Details
Issue size, price, financials, and company info
Gaudium IVF IPO GMP
Live grey market premium and listing estimate
Gaudium IVF IPO Subscription
QIB, NII, Retail, SHNI and BHNI subscription
Gaudium IVF IPO Allotment
Allotment date, chances, and check by PAN
Gaudium IVF IPO Review
SWOT, strengths, risks, and IPO review
Gaudium IVF IPO FAQ
Common questions on dates, GMP, and allotment
Gaudium IVF IPO Registrar
Registrar website and how to check allotment
Gaudium IVF IPO Timeline
Open, close, allotment, and listing dates
Gaudium IVF IPO News
Updates, blogs, and latest IPO news
Sources
We match Gaudium IVF IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- Bigshare Services Pvt.Ltd.Official site to check allotment status for this IPO
Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews IPO dates and key details before they go live.